Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
March 28, 2023 at 10:15 AM EDT
These titans of big pharma just enrolled patients into phase 3 clinical trials for this promising blood thinner.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.